Piolax, Inc. Reports Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the Six Months and Year Ending March 31, 2019
May 21, 2018
Share
Piolax, Inc. reported consolidated earnings results for the year ended March 31, 2018. For the year, the company reported net sales of JPY 67,876 million as compared to JPY 64,275 million for the same period last year. Operating income was JPY 10,220 million as compared to JPY 10,384 million for the same period last year. Ordinary income was JPY 10,987 million as compared to JPY 11,429 million for the same period last year. Net income attributable to owners of PIOLAX Inc. was JPY 8,126 million as compared to JPY 8,003 million for the same period last year. Net income per share was JPY 226.91 as compared to JPY 223.48 for the same period last year. Net cash flows from operating activities was JPY 9,853 million as compared to JPY 10,541 million for the same period last year. Net income before taxes and other adjustments was JPY 10,725 million as compared to JPY 11,340 million for the same period last year.
For the six months of the year ending March 31, 2019, the company expects Net sales of JPY 33,100 million, operating income of JPY 4,500 million, ordinary income of JPY 5,200 million, net income attributable to owners of PIOLAX Inc. of JPY 3,600 million and net income per share of JPY 100.52.
For the year ending March 31, 2019, the company expects Net sales of JPY 67,000 million, operating income of JPY 9,500 million, ordinary income of JPY 10,800 million, net income attributable to owners of PIOLAX Inc. of JPY 7,200 million and net income per share of JPY 201.03.
PIOLAX, INC. is a Japan-based company principally engaged in the manufacture and sale of automotive related products. The Company operates in two business segments. Automotive Related Business segment is mainly involved in the manufacture and sale of precision springs, industrial fasteners, as well as small unit parts that combine resin and metal to the automobile industry. Medical Equipment Business segment is involved in the manufacture and sale of interventional radiology (IVR), endoscopic treatment, and orthopedic treatment equipment to medical institutions.
Piolax, Inc. Reports Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the Six Months and Year Ending March 31, 2019